Postprandial changes in LDL phenotypes in patients with myocardial infarction

European Journal of Clinical Investigation

Volumn 35, Issue 3, 2005, Pages 171-179

  Koba, S ^a,b   Tsunoda, F ^a,b   Hirano, T ^a,b   Iso, Y ^a,b   Suzuki, H ^a,b   Geshi, E ^a,b   Katagiri, T ^a,b  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Dense LDL; Intermediate sized LDL postprandial hyperlipaemia; Remnant like particle myocardial infarction; Small

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PARTICLE SIZE; PHENOTYPE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ELECTROPHORESIS, AGAR GEL; FASTING; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARTICLE SIZE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 14844292170     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01469.x     Document Type: Article

References (44)

1. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willen WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
3. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994;5:395-403.
4. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-8.
5. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR Lupien PJ et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998;279:1955-61.
6. Gardner CD, Fortmann SP, Krauss RM. Association of small dense low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
7. Koba S, Hirano T. Small dense low-density lipoprotein in Japanese men with coronary artery disease. Ann Intern Med 2000;132:762. [Letter]
8. Koba S, Hirano T, Yoshino G, Sakai K, Sakaue T, Adachi M et al. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 2002;160:249-56.
9. Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart diseases. Am Heart J 2002;144:1026-35.
10. Packard C, Caslake M, Shepherd J. The role of small, dense low density lipoprotein (LDL): a new look. Int J Cardiol 2000;74:S17-22.
11. Lemieux I, Couillard C, Pascot A, Bergeron N, Prud'homme D, Bergeron J et al. The small dense LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis 2000;153:423-32.
12. Nikkilä M, Solakivi T, Lehtimäki T, Koivula T, Laippala P, Åström B. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 1994;106:149-57.
13. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceide metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 1992;12:1496-502.
14. Nakajima K, Saito K, Tamura A, Suzuki M, Nakano T, Adachi M et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apoA-1 immunoaffinity mixed gels. Clin Chim Acta 1993;223:53-71.
15. Schaefer EJ, Audelin MC, McNamara JR, Shah PK, Tayler T, Daly JA et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol 2001;88:1129-33.
16. Tanaka A, Tomie N, Nakano T, Nakajima K, Yui K, Tamura M et al. Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test. Clin Chim Acta 1998;275:43-52.
17. Saito Y. J Atheroscler Thromb 2004;11:101-3. [Editorial]
18. Nakamura M, Taniguchi Y, Yamamoto M, Hino K, Manabe M. Homogenous assay of serum LDL-cholesterol on automatic analyzer. Clin Chem 1997;43:S260-1.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment, insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-29.
20. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Meth Enzymol 1986;128:417-33.
21. Lamarche B, Lemieux I, Després JP. The small, dense LDL phenotype and the risk of coronary heart disease: Epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 1999;25:199-211.
22. Attia N, Durlach V, Paul JL, Soni T, Betoulle D, Girard-Globa A. Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin dependent diabetic subjects. Atherosclerosis 1995;113:197-209.
23. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low density liporotein subfraction distribution. Arteriosclerosis 1987;7:483-90.
24. Tan KCB, Cooper MB, Eddie Ling KL, Griffin BA, Freeman DJ, Packard CJ et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 1995;113:273-87.
25. Ashida Y, Takagi A, Ikeda Y. Improved method for non-denaturing polyacrylamide gradient gel electrophoresis for detecting of small-sized LDL produced during postprandial hypertriglyceridemia. Scand J Clin Lab Invest 1999;59:663-70.
26. Pirro M, Lupattelli G, Siepi D, Palumbo B, Roscini AR, Marchesi S et al. Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women. Metabolism 2001;50:330-4.
27. Lupattelli G, Passqualini L, Siepi D, Marchesi S, Pirro M, Vaudo G et al. Increased postprandial lipemia in patients with normolipemic peripheral arterial disease. Am Heart J 2002;143:733-8.
28. Blackburn P, Cote M, Lamarche B, Couillard C, Pascot A, Tremblay A et al. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism 2003;52:1379-86.
29. Packard CJ, Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Areterioscler Thromb Vasc Biol 1997;17:3542-56.
30. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002;43:1363-79.
31. Demant T, Packard C. In vivo studies of VLDL metabolism and LDL heterogeneity. Eur Heart J 1998;19 (Suppl. H):H7-10.
32. Ikeda Y, Ashida Y, Takagi A, Fukuda T, Tsuru A, Tsushima M et al. Mechanism of the production of small dense LDL in hypertriglyceridemia. In: Jacotot B, Mathé D, Fruchart JC, eds. Atherosclerosis XI. Singapore: Elsevier Science, 1998.pp. 777-88.
33. Koba S, Hirano T, Murayama S, Kotani T, Tsunoda F, Iso Y et al. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis 2003;170:131-40.
34. Karpe F, Steiner G, Olivecrona T. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993;91:748-59.
35. Karpe F. Postprandial lipid metabolism in relation to coronary heart disease. P Nutr Soc 1997;56:671-8.
36. Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 1992;33:369-80.
37. Campos E, Kotite L, Blanche P, Mitsugi Y, Frost PH, Masharani U et al. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. J Lipid Res 2002;43:365-74.
38. Tall A, Sammett D, Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest 1986;77:1163-72.
39. Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baumstark MW et al. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 2003;88:1162-6.
40. 2 cholesterol in normolipidemic men with coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:1043-8.
41. Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, Pravastatin treatment, and coronary events. JAMA 2001;286:1468-74.
42. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
43. Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 2000;41:305-17.
44. Berneis K, Shames DM, Blanche PJ, Belle ML, Rizzo M, Krauss RM. Plasma clearance of human low-density liporotein in human apolipoprotein B transgenic mice is related to particle diameter. Metabolism 2004;53:483-7.